Enrelvamento em vinha de encosta não regada: 2 - efeitos no crescimento vegetativo, produção e qualidade do mosto e vinho, casta Cabernet Sauvignon

Grapevine vegetative growth, yield, fruit composition and wine quality were studied in the Estremadura Winegrowing Region of Portugal in a ‘Cabernet Sauvignon’ slopping non-irrigated vineyard. During three seasons three treatments were compared: soil tillage (control), permanent resident vegetation, and permanent sown cover crop. When compared to soil tillage, the inter-row sward treatments displayed a lower predawn leaf water potential from bloom to mid-ripening. These differences in vine water status did not affect vine yield or berry sugar accumulation; however, in the third season after experiment setup it induced a significant reduction in vegetative growth in the sward treatments, compared to soil tillage. This vegetative growth reduction had a positive effect on grape composition by reducing titratable acidity and increasing berry skin total phenols and anthocyanins. Those differences were also detected in the wines by the judges who gave a better classification to the wines from the sward treatments. Our results indicate that cover cropping can be a valuable tool for controlling vigour and enhancing wine quality in this winegrowing region

Enrelvamento em vinha de encosta não regada: 1 - efeito na composição e dinâmica das infestantes

The influence of two sward treatments and soil cultivation on the composition, the structure, and the evolution of the biomass of vineyard weed communities was examined. The 3-year study (2002-2004) was carried out in a sloping, non-irrigated vineyard, cv. ‘Cabernet Sauvignon’, in the Estremadura winegrowing region of Portugal. The experimental treatments were: soil tillage (control); permanent sown cover crop - Lolium perenne ‘Nui’, L. multiflorum ‘Bartíssimo’, Festuca ovina ‘Ridu’, F. rubra ssp. rubra ‘Echo’, Trifolium incarnatum. ‘Red’, T. repens ‘Huie’ and T. subterraneum ‘Claire’; and permanent resident vegetation. Total weed biomass in the spring did not reveal significant differences between treatments, but varied annually. The management practices – e.g. time and number of soil cultivations and inter-row mowing – were determinant in weed biomass evolution. Canonical correspondence analysis revealed significant treatment effects on community structure. Three years after the experiment was set up, in the soil tillage treatment weed composition was dominated by annual broad-leaved species, namely five Geraniaceae species, Medicago polymorpha and Sonchus oleraceus. The perennial broad-leaved species Oxalis pes-caprae was also a dominant species in soil tillage. In both sward treatments there was an increase in the perennial broad-leaved and grass species. Compared to soil tillage, in the resident vegetation treatment there was a significant increase in perennial species, such as Rumex crispus, Veronica anagallis-aquatica and Polypogon monspeliensis, and in the annuals Melilotus indica and Avena sterilis. The increase in these perennial species, which are considered to compete with vines, requires more frequent mowing in the summer. In the permanent sown cover crop treatment, L. perenne and T. repens displayed the ability to re-establish successfully, and their abundance decreased or suppressed most of the annual and perennial weed species

Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update

Growing consistent evidence indicates that hypofunction of N-methyl-D-aspartate (NMDA) transmission plays a pivotal role in the neuropathophysiology of schizophrenia. Hence, drugs which modulate NMDA neurotransmission are promising approaches to the treatment of schizophrenia. The aim of this article is to review clinical trials with novel compounds acting on the NMDA receptor (NMDA-R). This review also includes a discussion and translation of neuroscience into schizophrenia therapeutics. Although the precise mechanism of action of minocycline in the brain remains unclear, there is evidence that it blocks the neurotoxicity of NMDA antagonists and may exert a differential effect on NMDA signaling pathways. We, therefore, hypothesize that the effects of minocycline on the brain may be partially modulated by the NMDA-R or related mechanisms. Thus, we have included a review of minocycline neuroscience. The search was performed in the PubMed, Web of Science, SciELO, and Lilacs databases. The results of glycine and D-cycloserine trials were conflicting regarding effectiveness on the negative and cognitive symptoms of schizophrenia. D-serine and D-alanine showed a potential effect on negative symptoms and on cognitive deficits. Sarcosine data indicated a considerable improvement as adjunctive therapy. Finally, minocycline add-on treatment appears to be effective on a broad range of psychopathology in patients with schizophrenia. The differential modulation of NMDA-R neurosystems, in particular synaptic versus extrasynaptic NMDA-R activation and specific subtypes of NMDA-R, may be the key mediators of neurogenesis and neuroprotection. Thus, psychotropics modulating NMDA-R neurotransmission may represent future monotherapy or add-on treatment strategies in the treatment of schizophrenia

The DNA damage response is developmentally regulated in the African trypanosome

Genomes are affected by a wide range of damage, which has resulted in the evolution of a number of widely conserved DNA repair pathways. Most of these repair reactions have been described in the African trypanosome Trypanosoma brucei, which is a genetically tractable eukaryotic microbe and important human and animal parasite, but little work has considered how the DNA damage response operates throughout the T. brucei life cycle. Using quantitative PCR we have assessed damage induction and repair in both the nuclear and mitochondrial genomes of the parasite. We show differing kinetics of repair for three forms of DNA damage, and dramatic differences in repair between replicative life cycle forms found in the testse fly midgut and the mammal. We find that mammal-infective T. brucei cells repair oxidative and crosslink-induced DNA damage more efficiently than tsetse-infective cells and, moreover, very distinct patterns of induction and repair of DNA alkylating damage in the two life cycle forms. We also reveal robust repair of DNA lesions in the highly unusual T. brucei mitochondrial genome (the kinetoplast). By examining mutants we show that nuclear alkylation damage is repaired by the concerted action of two repair pathways, and that Rad51 acts in kinetoplast repair. Finally, we correlate repair with cell cycle arrest and cell growth, revealing that induced DNA damage has strikingly differing effects on the two life cycle stages, with distinct timing of alkylation-induced cell cycle arrest and higher levels of damage induced death in mammal-infective cells. Our data reveal that T. brucei regulates the DNA damage response during its life cycle, a capacity that may be shared by many microbial pathogens that exist in variant environments during growth and transmission

Three-dimensional CFD analysis of the hand and forearm in swimming

The purpose of this study was to analyze the hydrodynamic characteristics of a realistic model of an elite swimmer hand/forearm using three-dimensional computational fluid dynamics techniques. A three-dimensional domain was designed to simulate the fluid flow around a swimmer hand and forearm model in different orientations (0°, 45°, and 90° for the three axes Ox, Oy and Oz). The hand/forearm model was obtained through computerized tomography scans. Steady-state analyses were performed using the commercial code Fluent. The drag coefficient presented higher values than the lift coefficient for all model orientations. The drag coefficient of the hand/forearm model increased with the angle of attack, with the maximum value of the force coefficient corresponding to an angle of attack of 90°. The drag coefficient obtained the highest value at an orientation of the hand plane in which the model was directly perpendicular to the direction of the flow. An important contribution of the lift coefficient was observed at an angle of attack of 45°, which could have an important role in the overall propulsive force production of the hand and forearm in swimming phases, when the angle of attack is near 45°.Lif

Computational fluid dynamics applied to competitive swimming: the role of finger position

The best fingers’ relative position during the underwater path of the stroke cycle in swimming seems to be an unclear issue. Even in elite level swimmers, different relative positions of thumb and finger spreading can be observed. The aim of the current abstract was to present the hydrodynamic characteristics of a true model of a swimmer’s hand with different fingers’ positions using computational CFD

Swimming propulsion forces are enhanced by a small finger spread

The main aim of this study was to investigate the effect of finger spread on the propulsive force production in swimming using computational fluid dynamics. Computer tomography scans of an Olympic swimmer hand were conducted. This procedure involved three models of the hand with differing finger spreads: fingers closed together (no spread), fingers with a small (0.32 cm) spread, and fingers with large (0.64 cm) spread. Steady-state computational fluid dynamics analyses were performed using the Fluent code. The measured forces on the hand models were decomposed into drag and lift coefficients. For hand models, angles of attack of 0°, 15°, 30°, 45°, 60°, 75°, and 90°, with a sweep back angle of 0°, were used for the calculations. The results showed that the model with a small spread between fingers presented higher values of drag coefficient than did the models with fingers closed and fingers with a large spread. One can note that the drag coefficient presented the highest values for an attack angle of 90° in the three hand models. The lift coefficient resembled a sinusoidal curve across the attack angle. The values for the lift coefficient presented few differences among the three models, for a given attack angle. These results suggested that fingers slightly spread could allow the hand to create more propulsive force during swimming

Monitoring Of Bcr-abl Levels In Chronic Myeloid Leukemia Patients Treated With Imatinib In The Chronic Phase - The Importance Of A Major Molecular Response

Background: Real time PCR has become the most common technique to monitor BCR-ABL transcript levels of patients treated with kinase inhibitors. The aim of this study was to evaluate BCR-ABL levels of chronic myeloid leukemia patients treated with imatinib in the chronic phase and correlate the response to therapy and event-free survival. Methods: BCR-ABL levels were measured in peripheral blood cell samples using Real time PCR at diagnosis and then every 3 months after starting therapy with imatinib. Major molecular response was defined as a three-log reduction from the standardized baseline value. Major molecular response values were adjusted to international scale using a conversion factor of 1.19. The results are reported as a BCR-ABL/ABL ratio (%). Results: Hematological, major cytogenetic and complete cytogenetic responses were achieved by 57 (95%), 45 (75%) and 38 (63%) patients, respectively. Twenty-four out of sixty patients achieved a major molecular response (40%) in a median time of 8.5 months. Overall survival and event free survival were higher for patients with (100%) versus patients without (77%) a complete cytogenetic response (p-value = 0.01) at 48 months. Patients with complete cytogenetic response and major molecular response had a higher event free survival compared to patients with complete cytogenetic response but without major molecular response (p-value = 0.007). Conclusion: In conclusion, the prognostic impact of achieving complete cytogenetic response and a major molecular response and also the importance of molecular monitoring in the follow-up of chronic myeloid leukemia patients were demonstrated.333211215Melo, J.V., The molecular biology of chronic myeloid leukaemia (1996) Leukemia, 10 (5), pp. 751-756Wang, L., Pearson, K., Pillitteri, L., Ferguson, J.E., Clark, R.E., Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia (2002) Br J Haematol, 118 (3), pp. 771-777Muller, M.C., Gattermann, N., Lahaye, T., Deininger, M.W., Berndt, A., Fruehauf, S., Dynamics of BCR-ABL mRNA expression in firstline therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C (2003) Leukemia, 17 (12), pp. 2392-2400Branford, S., Hughes, T.P., Rudzki, Z., Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics (1999) Br J Haematol, 107 (3), pp. 587-599Radich, J.P., Gooley, T., Bryant, E., Chauncey, T., Clift, R., Beppu, L., The significance of bcr-abl molecular detection in chronic myeloid leukemia patients late, 18 months or more after transplantation (2001) Blood, 98 (6), pp. 1701-1707Hughes, T.P., Kaeda, J., Branford, S., Rudzki, Z., Hochhaus, A., Hensley, M.L., Frequency of major molecular responses to imatinib or interferon-alpha plus cytarabine in newly diagnosed chronic myeloid leukemia (2003) N Engl J Med, 349 (15), pp. 1423-1432Press, R.D., Love, Z., Tronnes, A.A., Yang, R., Tran, T., Mongoue- tchokote, S., BCR-ABL mRNA levels at and after the time of a complete cytogenetic response predict the duration of CCR in imatinib mesylate-treated patients with CML (2006) Blood, 107 (11), pp. 4250-4256Cortes, J., Talpaz, M., O'Brien, S., Jones, D., Luthra, R., Shan, J., Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate (2005) Clin Cancer Res, 11 (9), pp. 3425-3432Iacobucci, I., Saglio, G., Rosti, G., Testoni, N., Pane, F., Amabile, M., Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients (2006) Clin Cancer Res, 12 (10), pp. 3037-3042Baccarani, M., Saglio, G., Goldman, J., Hochhaus, A., Simonsson, B., Appelbaum, F., Evolving concepts in the management of chronic myeloid leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet (2006) Blood, 108 (6), pp. 1809-1820Hughes, T., Deininger, M., Hochhaus, A., Branford, S., Radich, J., Kaeda, J., Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: Review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results (2006) Blood, 108 (1), pp. 28-37Branford, S., Cross, N.C., Hochhaus, A., Radich, J., Saglio, G., Kaeda, J., Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia (2006) Leukemia, 20 (11), pp. 1925-1930Cortes, J., Baccarani, M., Fea, G., (2008) A Phase III, Randomized, Openlabel Study of 400 Mg Versus 800 Mg of Imatinib Mesylate (IM) in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP), Using Molecular Endpoints: One Year Results of TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) Study, , 50th ASH Annual Meeting and Exposition Online program and Abstracts. San Francisco, CABranford, S., Fletcher, L., Cross, N.C., Muller, M.C., Hochhaus, A., Kim, D.W., Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials (2008) Blood, 112 (8), pp. 3330-3338O'Brien, S.G., Guilhot, F., Larson, R.A., Gathmann, I., Baccarani, M., Cervantes, F., Imatinib compared with interferon and lowdose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia (2003) N Engl J Med, 348 (11), pp. 994-1004Marin, D., Milojkovic, D., Olavarria, E., Khorashad, J.S., de Lavallade, H., Reid, A.G., European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor (2008) Blood, 112 (12), pp. 4437-444

A phase-field model of Hele-Shaw flows in the high viscosity contrast regime

A one-sided phase-field model is proposed to study the dynamics of unstable interfaces of Hele-Shaw flows in the high viscosity contrast regime. The corresponding macroscopic equations are obtained by means of an asymptotic expansion from the phase-field model. Numerical integrations of the phase-field model in a rectangular Hele-Shaw cell reproduce finger competition with the final evolution to a steady state finger the width of which goes to one half of the channel width as the velocity increases

Continuous infusion of propofol after ketamine-midazolam premedication in cats

Estudaram-se os efeitos anestésicos e cardiorrespiratórios produzidos pela infusão contínua de propofol em gatos pré-medicados com a associação cetamina-midazolam. Catorze gatos adultos foram igualmente distribuídos em dois grupos (TX1 e TX3) aos quais administraram-se, pela via intramuscular, cetamina (3,0mg/kg) e midazolam (0,3mg/kg). Decorridos cinco minutos procedeu-se a indução anestésica pela administração intravenosa de propofol (5,0mg/kg), imediatamente seguida pela infusão contínua do agente hipnótico nas doses de 0,1 ou 0,3mg/kg/min, aos animais de TX1 e TX3, respectivamente. Foram mensuradas as freqüências cardíaca e respiratória, temperatura retal, saturação de oxihemoglobina, concentração exalada de dióxido de carbono e pressão arterial. Em TX3 observou-se manutenção de adequado plano anestésico, enquanto que os animais do TX1 apresentaram-se sedados. Houve decréscimo acentuado da freqüência cardíaca, pressão arterial e elevação da concentração de dióxido de carbono exalado no TX3. Conclui-se que o emprego de propofol na dose de infusão de 0,3mg/kg/min em gatos pré-medicados com cetamina-midazolam produz anestesia satisfatória, bradicardia, depressão da função respiratória e pressão arterial.Anesthetic and cardiorespiratory effects of two different infusion rates of propofol were studied in cats premedicated with ketamine-midazolam. Fourteen cats were assigned to one of the two groups (TX1 or TX3). Ketamine (3.0mg/kg) and midazolam (0.3mg/kg) were administered intramuscularly. After 5 minutes, anesthesia was induced by propofol (5.0mg/kg) and maintained by a continuous infusion of propofol (0.1 and 0.3mg/kg/min, TX1 and TX3, respectively). Heart and respiratory rate, rectal temperature, oxygen hemoglobin saturation, end-tidal carbon dioxide and arterial pressure were recorded. Adequate anesthesia was observed in TX3, while animals in TX1 were only lightly sedated. A greater decrease in heart rate, arterial pressure and elevation of end-tidal dioxide carbon was observed in TX3 compared to TX1. It was concluded that administration of propofol at infusion rate of 0.3mg/kg/min provides satisfatory anesthesia, but it results in bradycardia, depression of respiratory function and arterial pressure